Volume : 11, Issue : 08, August – 2024
Title:
PHYTOCHEMICAL EVALUATION AND CNS ACTIVITIES OF TRADESCANTIA SPATHACEA ON ALBINO MICE
Authors :
Rangam Chariitha*Musarrath Mubeen, Chinthala Ravikanth
Abstract :
Depression is considered as affective mood disorder which is characterized by change in mood, lack of confidence etc. depression is the most prevalent disorder and the symptoms associated with depression changes the neurotransmitter levels in brain such as norepinephrine, seritonine and dopamine. Tradescantia spathacea is the plant selected to be used as a test drug in experimental animals. After selecting the plant, it has been dried and powdered, which was futher extracted using methanol as a solvent in a soxhlet apparatus. The evaluation of CNS activity has been done on mice of four groups by following standard procedures with the help of experimental methods such as Muscle Relaxant Property By Rotarod Apparatus, Anti Anxiety Effect By Elevated Plus Maze Apparatus and Anti Depressant Activity By Using Actophotometer to evaluate the potency of the drug and to know its activity. After comparing the test drug (Diazepam) with standard (Plant extract), results have shown that the extract has CNS activity. Therefore, it is concluded that Tradescantia spathacea extract has strong CNS activity on mice.
Key Words: seritonine, dopamine, Tradescantia spathacea, Anti-Depressant Activity, and standard drug (Diazepam).
Cite This Article:
Please cite this article in press Rangam Chariitha et al., Phytochemical Evaluation And CNS Activities Of Tradescantia Spathacea On Albino Mice., Indo Am. J. P. Sci, 2024; 11 (08).
Number of Downloads : 10
References:
1.The World Health Report. Mental health: new understanding new hope. WHO, Geneva, 2001.
2.Reynolds EH. Brain and mind: a challenge for WHO. Lancet 2003; 361; 1924-1925.
3.Noble S, Benfield P. Citalopram: a review of its pharmacology, clinical efficacy and tolerability in the treatment of depression. CNS Drugs 1997; 8: 410-31.
4.Wilde MI, Plosker GL, Benfield P. Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness. Drugs 1993;46:895-924.
5.Holliday SM, Benfield P. Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs 1995;49:280-94.
6.Davis R, Whittington R, Bryson HM. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. Drugs 1997;53:608-36.
7.Brunton, L. L.; Chabner, Bruce; Knollmann, Björn C., eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics (12th ed.). New York: McGraw-Hill. (2011).
8.Maes, M; Yirmyia, et al. “The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression”.Metabolic Brain Disease. March 2009; 24 (1):
9.Sanacora, G; Treccani, G; Popoli, M. “Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders” (PDF). Neuropharmacology. January 2012; 62 (1):
10.Menke A, Klengel T, Binder EB (2012). “Epigenetics, depression and antidepressant treatment”. Current Pharmaceutical Design 18
11.Vialou, V; Feng, J; Robison, AJ; Nestler, EJ (January 2013). “Epigenetic mechanisms of depression and antidepressant action”. Annual Review of Pharmacology and Toxicology 53(1): 59–87
12.Dillon C, Paulose-Ram R, Hirsch R. et al. Skeletal Muscle Relaxant Use in the United States: Data from the Third National Health and Nutrition Examination Survey (NHANES III) Spine. 2004;29(8): 892–896.
13.Rebeca García Varela, Rebeca M. García-García , Bertha A. Barba-Dávila , Oscar R. Fajardo-Ramírez , Sergio O. Serna-Saldívar and Guy A. Cardineau. Antimicrobial Activity of Rhoeo discolor Phenolic Rich Extracts Determined by Flow Cytometry. Molecules 2015; 20: 18685-18703.
14.GONZÁLEZ-AVILA M, ARRIAGA-ALBA M, DE LA GARZA M, DEL CARMEN HERNÁNDEZPRETELÍN M, DOMÍNGUEZ-ORTÍZ MA, FATTEL-FAZENDA S, VILLA-TREVIÑO S. ANTIGENOTOXIC, ANTIMUTAGENIC AND ROS SCAVENGING ACTIVITIES OF A RHOEO DISCOLOR ETHANOLIC CRUDE EXTRACT. TOXICOL IN VITRO. 2003 FEB;17(1):77-83.
14.Tabata Rosales-Reyes , Mireya de la Garza , Carlos Arias-Castro, Martha Rodr´ıguez-Mendiola , SamiaFattel-Fazenda , Evelia Arce-Popoca , Sergio Hernandez-Garc , Saul Villa-Trevi. Aqueous crude extract of Rhoeo discolor, a Mexican medicinal plant, decreases the formation of liver preneoplastic foci in rats. Journal of Ethnopharmacology. 2008; 115: 381–386.
15.VaradarajanParivuguna, RathinaswamyGnanaprabhal, RangasamyDhanabalan and Asirvatahm Doss Antimicrobial Properties and Phytochemical Constituents of Rheo discolor Hance. Ethnobotanical Leaflets 12; 841-45. 2008.
16.seetharamaiahnandini, seetharamaiahnalini, sangarajushanmugam, pathappa niranjana, jose saviomelo and gurukarshivappa suresh, rhoeo discolor leaf extract as a novel immobilizing matrix for the fabrication of an electrochemical glucose and hydrogen peroxide biosensor.anal. methods, 2014;6: 863-877.
17.Tábata Rosales-Reyes, Mireya de la Garza, Carlos Arias-Castro, Martha Rodríguez-Mendiola, SamiaFattel-Fazenda, Evelia Arce-Popoca, Sergio Hernández-García, Saúl Villa-Treviño. Aqueous crude extract of Rhoeo discolor, a Mexican Medicinal Plant, decreases the formation on liver preneoplastic foci in rats.Journal of Ethnopharmacology, 115; 2008: 381-386.
18.Arriaga-Alba Myriam, Blasco José Luis, Ruíz-Pérez Nancy Jannetea, Sánchez-Navarrete Jaime, Rivera-Sánchez Roberto, González-Avila Marisela. Antimutagenicity mechanisms of the Rhoeo discolor ethanolic extract. Experimental and Toxicologic Pathology, Volume 63, Issue 3, March 2011, Pages 243–248.
19.Reyes-Munguı´aa , E. Azu´ara-Nietoc , C.I. Beristainc, F. Cruz-Sosaa and E.J. Vernon-Carterb. Propiedadesantioxidantesdel maguey morado (Rhoeo discolor) Purple maguey (Rhoeo discolor) antioxidant properties. CyTA – Journal of Food Vol. 7, No. 3, November 2009: 209–216.
20.Floridata: Tradescantiaspathacea [Online] Retrieved 21-11-2014.
21.Invasive Species Compendium. Tradescantiaspathacea datasheet. Retrieved 21-11-2014.
22.David R. Hunt, (1986). “Campelia, Rhoeo and Zebrina united with Tradescantia: American Commelinaceae: XIII“. Kew Bulletin 41 (2): 401–405.
23.Kew Royal Botanic Gardens. World Checklist of Selected Plant Families [Online. Retrieved 21-11-2014.
24.Angiosperm Phylogeny Website. Commelinaceae family. [Online] Retrieved 21-11-2014.
25.SadaoChikawa, (1972). “Somatic Mutation Rate in Tradescantia Stamen Hairs at Low Radiation Levels: Finding of Low Doubling Doses of Mutations“. The Japanese Journal of Genetics 47 (6): 411–421.
26.Jean H. Burns, Robert B. Faden, and Scott J. Steppan (2011). Phylogenetic Studies in the Commelinaceae Subfamily Commelinoideae Inferred from Nuclear Ribosomal and Chloroplast DNA Sequences. Systematic Botany, 36(2):268-276.
27.Cryan J F, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. TrendsPharmacolSci 2002, 23: 238–245.
28.Cryan JF, Valentino RJ, Lucki I. Assessing substrates underlying the behavioural effects of antidepressants using the modified rat forced swimming test. NeurosciBiobehav Rev 2005, 29:547–69.
29.Petit-DemouliereB, Chenu F, Bourin M. Forced swimming test in mice: a review of antidepressant activity. J Psychopharmacology 2005, 177: 245–55.
30.Steru. L, Chemat. R, The tail suspension test: A novel method for screening antidepressants in mice. Psychopharmacology 1985;85:367-70.
31.Ratheesh M and Helen A: Anti-inflammatory activity of Rutugraveolens Linn. On Carrageenan induced paw edema in Wistar male rats. Afr J Biotech. 2007, 6(10), 1209-1211.
32.Porsalt RD, Bertin A, Jalfre M. Behavioural despair in mice: a primary screening test for antidepressants. Archives internationals de pharmacodynamicetTherapie 1977, (229): 327-336.
33.Johnson NJT, Rodgers RJ. 1996. Ethological analysisof cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice. Psychopharmacology, (124): 355- 364.